IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Spain

  • ID: 1408496
  • Report
  • Region: Spain
  • 48 Pages
  • IMS Health
1 of 3
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.

This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Note: Product cover images may vary from those shown
2 of 3
1. HEALTHCARE SYSTEM
Facts & Figures
Market Indicators
Provision & Funding
National Health Service
Decentralisation
Funding
Provision

2. PRICING
Prescription Drugs
Reimbursed Drugs
Non-reimbursed Drugs
Mandatory Distribution Chain Discounts
Generic Drugs
Hospital Drugs
Risk-sharing and Expenditure Agreements
Reference Prices
Regional Centralised Purchasing
National Centralised Purchasing
OTC Drugs

3. REIMBURSEMENT
Admission to Reimbursement
Reimbursement Decisions
Negative List
Local Listing
Reimbursement Categories
Reimbursement Prices
Reference Prices
Cheapest Price/‘Actual’ Cheapest Price
Selective Reimbursement Prices
Andalucía Retail Sector Tenders
Hospital Reimbursement
Formularies
Funding
Out-patient Dispensing
Changes in Reimbursement Status
Changes in Reimbursement Prices
Price Revisions
Price Increases
Price Decreases
Mandatory Distribution Chain Discounts

4. PHARMACOECONOMICS
Pharmacoeconomic Requirements
HTA Developments
Draft Royal Decree

5. PRICE BUILD UP
Wholesalers
Margins
Mandatory Discounts
Background
Retail Pharmacies
Margins
Mandatory Discounts
Other Discounts
Pharmacy Clawbacks
Extra Financial Support
Pharmacy Provision & Regulation
E-pharmacy
Unit Dose Dispensing
Dispensing Doctors
Sales Tax

6. COST CONTAINMENT
Industry Paybacks
Risk-sharing/Maximum Expenditure Agreements
Industry Pact
Promotional Costs
Patient Co-payments
Pharmaceuticals
Healthcare
Prescribing Controls
National Controls
Regional Drug Evaluation Committees
Regional Prescribing Targets
Regional Electronic Prescribing Systems
Regional Visas
Regional Listing
Generics
INN Prescribing
Dispensing Decisions
Generic Substitution
Promotion of Generics
Rx-to-OTC Switches
Parallel Trade
Drug Tracing

7. FUTURE DEVELOPMENTS
Outlook
Royal Decree on Pricing and Reimbursement
Government Pacts with Industry
National vs Regional Control

8. NAMES & ADDRESSES
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll